HSS Studies Challenge Pediatric Orthopedic Treatment Norms

Event summary

  • HSS presented two studies at the 2026 AAOS annual meeting that could alter pediatric orthopedic care guidelines.
  • 95% of adolescent athletes with lumbar spine stress fractures healed without surgery, per HSS study of 179 patients.
  • Growth hormone therapy linked to higher physeal fracture rates in children, according to HSS analysis of 34,196 patients.
  • Studies suggest non-operative approaches for spondylolysis and caution about GH therapy risks.

The big picture

These findings challenge conventional approaches to common pediatric orthopedic conditions, potentially reducing unnecessary surgeries while raising concerns about widely used growth hormone treatments. The studies position HSS as a thought leader in evidence-based pediatric orthopedic care, with implications for both clinical practice and healthcare policy. The research comes at a time when pediatric orthopedic care is under increasing scrutiny for both cost and outcomes.

What we're watching

Protocol Adoption
How quickly pediatric orthopedic practices will incorporate these findings into standard care.
Regulatory Scrutiny
Whether these findings prompt new safety guidelines for growth hormone therapy.
Insurance Impact
The pace at which payers adjust coverage policies based on these treatment recommendations.